SNN – Smith & Nephew plc
SNN — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
0.69
Margin Of Safety %
8
Put/Call OI Ratio
0.26
EPS Next Q Diff
EPS Last/This Y
0.42
EPS This/Next Y
0.23
Price
30.06
Target Price
37.17
Analyst Recom
2.35
Performance Q
-15.04
Upside
5.4%
Beta
0.6
Ticker: SNN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-13 | SNN | 34 | 0.19 | 0.00 | 615 |
| 2026-04-14 | SNN | 34.35 | 0.19 | 0.00 | 615 |
| 2026-04-15 | SNN | 34.22 | 0.18 | 0.00 | 622 |
| 2026-04-20 | SNN | 34.21 | 0.19 | 0.00 | 616 |
| 2026-04-23 | SNN | 31.91 | 0.19 | 0.00 | 616 |
| 2026-04-24 | SNN | 31.57 | 0.19 | 0.00 | 616 |
| 2026-04-27 | SNN | 32.1 | 0.19 | 2.00 | 617 |
| 2026-04-28 | SNN | 31.06 | 0.19 | 0.00 | 621 |
| 2026-04-29 | SNN | 30.38 | 0.19 | 0.00 | 622 |
| 2026-04-30 | SNN | 30.92 | 0.19 | 999.99 | 622 |
| 2026-05-01 | SNN | 31.16 | 0.19 | 999.99 | 622 |
| 2026-05-04 | SNN | 30.9 | 0.19 | 999.99 | 622 |
| 2026-05-05 | SNN | 31.31 | 0.19 | 999.99 | 623 |
| 2026-05-06 | SNN | 30.25 | 0.22 | 4.42 | 639 |
| 2026-05-07 | SNN | 30.07 | 0.25 | 999.99 | 661 |
| 2026-05-08 | SNN | 29.94 | 0.25 | 999.99 | 661 |
| 2026-05-11 | SNN | 29.1 | 0.26 | 999.99 | 662 |
| 2026-05-12 | SNN | 30.06 | 0.26 | 999.99 | 662 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-13 | SNN | 33.99 | - | 10.0 | 2.05 |
| 2026-04-14 | SNN | 34.35 | - | 39.8 | 2.05 |
| 2026-04-15 | SNN | 34.21 | - | 15.2 | 2.05 |
| 2026-04-16 | SNN | 33.83 | - | 2.9 | 2.05 |
| 2026-04-17 | SNN | 34.34 | - | 22.0 | 2.05 |
| 2026-04-20 | SNN | 34.22 | - | 11.6 | 2.05 |
| 2026-04-21 | SNN | 32.83 | - | -15.5 | 2.05 |
| 2026-04-22 | SNN | 32.75 | - | 6.4 | 2.05 |
| 2026-04-23 | SNN | 31.91 | - | -8.7 | 2.05 |
| 2026-04-24 | SNN | 31.57 | - | 3.2 | 2.05 |
| 2026-04-27 | SNN | 32.09 | - | 36.9 | 2.05 |
| 2026-04-28 | SNN | 31.06 | - | -8.8 | 2.05 |
| 2026-04-30 | SNN | 30.92 | - | 21.2 | 2.05 |
| 2026-05-01 | SNN | 31.17 | - | -64.6 | 2.05 |
| 2026-05-04 | SNN | 30.90 | - | -71.1 | 2.05 |
| 2026-05-05 | SNN | 31.31 | - | -61.3 | 1.86 |
| 2026-05-06 | SNN | 30.25 | - | -95.9 | 1.86 |
| 2026-05-07 | SNN | 30.05 | - | -71.9 | 1.86 |
| 2026-05-08 | SNN | 29.94 | - | -73.5 | 1.86 |
| 2026-05-11 | SNN | 29.10 | - | -85.2 | 1.86 |
| 2026-05-12 | SNN | 30.06 | - | -50.6 | 1.86 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-13 | SNN | 0.00 | -1.44 | 0.80 |
| 2026-04-14 | SNN | 0.00 | -1.44 | 0.80 |
| 2026-04-15 | SNN | 0.00 | -1.44 | 0.80 |
| 2026-04-16 | SNN | 0.00 | -1.44 | 0.80 |
| 2026-04-17 | SNN | 0.00 | -1.44 | 0.80 |
| 2026-04-20 | SNN | 0.00 | -2.32 | 0.80 |
| 2026-04-21 | SNN | 0.00 | -2.32 | 0.80 |
| 2026-04-22 | SNN | 0.00 | -2.32 | 0.80 |
| 2026-04-23 | SNN | 0.00 | -2.32 | 0.80 |
| 2026-04-24 | SNN | 0.00 | -2.32 | 0.80 |
| 2026-04-27 | SNN | 0.00 | -3.51 | 0.72 |
| 2026-04-28 | SNN | 0.00 | -3.51 | 0.72 |
| 2026-04-29 | SNN | 0.00 | -3.51 | 0.72 |
| 2026-04-30 | SNN | 0.00 | -3.51 | 0.72 |
| 2026-05-01 | SNN | 0.00 | -3.51 | 0.72 |
| 2026-05-04 | SNN | 0.00 | -5.45 | 0.72 |
| 2026-05-05 | SNN | 0.00 | -5.45 | 0.72 |
| 2026-05-06 | SNN | 0.00 | -5.45 | 0.72 |
| 2026-05-07 | SNN | 0.00 | -5.45 | 0.72 |
| 2026-05-08 | SNN | 0.00 | -5.45 | 0.72 |
| 2026-05-11 | SNN | 0.00 | -3.35 | 0.72 |
| 2026-05-12 | SNN | 0.00 | -3.35 | 0.69 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-3.35
Beta
0.6
Average Sales Estimate Current Quarter
1503
Average Sales Estimate Next Quarter
1649
Fair Value
32.32
Quality Score
85
Growth Score
80
Sentiment Score
45
Actual DrawDown %
32.4
Max Drawdown 5-Year %
-49.2
Target Price
37.17
P/E
20.95
Forward P/E
12.27
PEG
1.24
P/S
2.08
P/B
2.41
P/Free Cash Flow
15.12
EPS
1.44
Average EPS Est. Cur. Y
1.86
EPS Next Y. (Est.)
2.09
Target Price Estimates Raised
1
Target Price Estimates Lowered
Profit Margin
10.14
Relative Volume
0.91
Return on Equity vs Sector %
-15
Return on Equity vs Industry %
EPS 1 7Days Diff
-0.2
EPS 1 30Days Diff
-0.19
EBIT Estimation
-50.6
◆
SNN
Healthcare
$30.06
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
39.1
Range 1M
16.8%
Sup Dist
4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
7.9%
EPS NY
11.3%
52W%
19%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+33.5% upside
Upside
+33.5%
Quality
85
MoS
8%
Smith & Nephew SNATS, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 16988
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
SNN
Latest News
—
Caricamento notizie per SNN…
stock quote shares SNN – Smith & Nephew plc Stock Price stock today
news today SNN – Smith & Nephew plc stock forecast ,stock prediction 2023 2024 2025
marketwatch SNN – Smith & Nephew plc yahoo finance google finance
stock history SNN – Smith & Nephew plc invest stock market
stock prices SNN premarket after hours
ticker SNN fair value insiders trading